SHMT1 and breast cancer: Therefore, we verified the interaction between miR-944 and SHMT1 and found that miR-944 could target and negatively regulate the expression of SHMT1, and the inhibitory effect of miR-944 overexpression on BC progression could be reversed by SHMT1 overexpression.